Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Lilja

Showing results (31-40 of 306) with videos related to

Pageof 31
Sort By:
Current Opinion in Urology|March 26, 2009
Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancerGeorge Botchorishvili, Mika P Matikainen, Hans Lilja
European Urology|October 18, 2018
Reply to Kathryn L. Penney, Massimo Loda, and Meir J. Stampfer's Letter to the Editor re: Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961-7Andrew J Vickers, Hans Lilja, Melissa Assel
Nature Reviews. Cancer|March 14, 2008
Prostate-specific antigen and prostate cancer: prediction, detection and monitoringHans Lilja, David Ulmert, Andrew J Vickers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Finasteride to prevent prostate cancer: should all men or only a high-risk subgroup be treated?Andrew J Vickers, Caroline J Savage, Hans Lilja
Annals of Internal Medicine|April 5, 2012
Screening for prostate cancerSigrid Carlsson, Andrew Vickers, Hans Lilja, et al.
Current Urology Reports|May 27, 2004
Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancerAlexander Haese, Markus Graefen, Hartwig Huland, et al.
European Urology|January 14, 2014
It ain't what you do, it's the way you do it: five golden rules for transforming prostate-specific antigen screeningAndrew Vickers, Sigrid Carlsson, Vincent Laudone, et al.
Clinical Chemistry|April 4, 2025
Toward Improved Prostate Cancer Screening: Insights from the Göteborg-2 TrialJacob E Tallman, Sigrid V Carlsson, Hans Lilja
Annual Review of Medicine|November 8, 2011
Screening for prostate cancer: early detection or overdetection?Andrew J Vickers, Monique J Roobol, Hans Lilja
Analytical Chemistry|April 25, 2015
Concurrent isolation of lymphocytes and granulocytes using prefocused free flow acoustophoresisCarl Grenvall, Cecilia Magnusson, Hans Lilja, et al.
Pageof 31

Showing results (31-40 of 306) with videos related to

Sort By:
Pageof 31
Current Opinion in Urology|March 26, 2009
Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancerGeorge Botchorishvili, Mika P Matikainen, Hans Lilja
European Urology|October 18, 2018
Reply to Kathryn L. Penney, Massimo Loda, and Meir J. Stampfer's Letter to the Editor re: Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961-7Andrew J Vickers, Hans Lilja, Melissa Assel
Nature Reviews. Cancer|March 14, 2008
Prostate-specific antigen and prostate cancer: prediction, detection and monitoringHans Lilja, David Ulmert, Andrew J Vickers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Finasteride to prevent prostate cancer: should all men or only a high-risk subgroup be treated?Andrew J Vickers, Caroline J Savage, Hans Lilja
Annals of Internal Medicine|April 5, 2012
Screening for prostate cancerSigrid Carlsson, Andrew Vickers, Hans Lilja, et al.
Current Urology Reports|May 27, 2004
Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancerAlexander Haese, Markus Graefen, Hartwig Huland, et al.
European Urology|January 14, 2014
It ain't what you do, it's the way you do it: five golden rules for transforming prostate-specific antigen screeningAndrew Vickers, Sigrid Carlsson, Vincent Laudone, et al.
Clinical Chemistry|April 4, 2025
Toward Improved Prostate Cancer Screening: Insights from the Göteborg-2 TrialJacob E Tallman, Sigrid V Carlsson, Hans Lilja
Annual Review of Medicine|November 8, 2011
Screening for prostate cancer: early detection or overdetection?Andrew J Vickers, Monique J Roobol, Hans Lilja
Analytical Chemistry|April 25, 2015
Concurrent isolation of lymphocytes and granulocytes using prefocused free flow acoustophoresisCarl Grenvall, Cecilia Magnusson, Hans Lilja, et al.
Pageof 31